Monday, December 11, 2023

Tag: Phase I/II dose-escalation

Zydus starts human dosing of its vaccine ‘ZyCoV-D’

Biotechnology Research Assistance Council (BIRAC) has announced that ZyCoV-D, the plasmid DNA vaccine designed and developed by Zydus and partially funded by the Department...

This function has been disabled for HealthTekPak.

error: Content is protected !!